Literature DB >> 21896644

TRB3 interacts with SMAD3 promoting tumor cell migration and invasion.

Fang Hua1, Rong Mu, Jinwen Liu, Jianfei Xue, Ziyan Wang, Heng Lin, Hongzhen Yang, Xiaoguang Chen, Zhuowei Hu.   

Abstract

Tribbles homolog 3 (TRB3, also known as TRIB3, NIPK and SKIP3), a human homolog of Drosophila Tribbles, has been found to interact with a variety of signaling molecules to regulate diverse cellular functions. Here, we report that TRB3 is a novel SMAD3-interacting protein. Expression of exogenous TRB3 enhanced the transcriptional activity of SMAD3, whereas knocking down endogenous TRB3 reduced the transcriptional activity of SMAD3. The kinase-like domain (KD) of TRB3 was responsible for the interaction with SMAD3 and the regulation of SMAD3-mediated transcriptional activity. In addition, TGF-β1 stimulation or overexpression of SMAD3 enhanced the TRB3 promoter activity and expression, suggesting that there is a positive feedback loop between TRB3 and TGF-β-SMAD3 signaling. Mechanistically, TRB3 was found to trigger the degradation of SMAD ubiquitin regulatory factor 2 (Smurf2), which resulted in a decrease in the degradation of SMAD2 and phosphorylated SMAD3. Moreover, TRB3-SMAD3 interaction promoted the nuclear localization of SMAD3 because of the interaction of TRB3 with the MH2 domain of SMAD3. These effects of TRB3 were responsible for potentiating the SMAD3-mediated activity. Furthermore, knockdown of endogenous TRB3 expression inhibited the migration and invasion of tumor cells in vitro, which were associated with an increase in the expression of E-cadherin and a decrease in the expression of Twist-1 and Snail, two master regulators of epithelial-to-mesenchymal transition, suggesting a crucial role for TRB3 in maintaining the mesenchymal status of tumor cells. These results demonstrate that TRB3 acts as a novel SMAD3-interacting protein to participate in the positive regulation of TGF-β-SMAD-mediated cellular biological functions. @ 2011. Published by The Company of Biologists Ltd

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21896644     DOI: 10.1242/jcs.082875

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  56 in total

1.  Whole genome expression profile in neuroblastoma cells exposed to 1-methyl-4-phenylpyridine.

Authors:  E Mazzio; K F A Soliman
Journal:  Neurotoxicology       Date:  2012-07-07       Impact factor: 4.294

2.  SLC9A3R1 stimulates autophagy via BECN1 stabilization in breast cancer cells.

Authors:  Hong Liu; Yan Ma; Hong-Wei He; Jia-Ping Wang; Jian-Dong Jiang; Rong-Guang Shao
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

3.  Trb3 regulates LR axis formation in zebrafish embryos.

Authors:  Mrudhula Anuppalle; Sateesh Maddirevula; Tae-Lin Huh; Myungchull Rhee
Journal:  Mol Cells       Date:  2013-11-27       Impact factor: 5.034

4.  A feed-forward loop involving Trib3, Akt and FoxO mediates death of NGF-deprived neurons.

Authors:  N Zareen; S C Biswas; L A Greene
Journal:  Cell Death Differ       Date:  2013-12       Impact factor: 15.828

5.  Tribbles Pseudokinase 3 Induces Both Apoptosis and Autophagy in Amyloid-β-induced Neuronal Death.

Authors:  Suraiya Saleem; Subhas Chandra Biswas
Journal:  J Biol Chem       Date:  2016-12-23       Impact factor: 5.157

6.  Metformin suppresses melanoma progression by inhibiting KAT5-mediated SMAD3 acetylation, transcriptional activity and TRIB3 expression.

Authors:  Ke Li; Ting-Ting Zhang; Feng Wang; Bing Cui; Chen-Xi Zhao; Jiao-Jiao Yu; Xiao-Xi Lv; Xiao-Wei Zhang; Zhao-Na Yang; Bo Huang; Xia Li; Fang Hua; Zhuo-Wei Hu
Journal:  Oncogene       Date:  2018-03-09       Impact factor: 9.867

7.  ELL Protein-associated Factor 2 (EAF2) Inhibits Transforming Growth Factor β Signaling through a Direct Interaction with Smad3.

Authors:  Xing Liu; Zhu Chen; Gang Ouyang; Tieshan Song; Huageng Liang; Wei Liu; Wuhan Xiao
Journal:  J Biol Chem       Date:  2015-09-14       Impact factor: 5.157

8.  Targeting pseudokinase TRIB3 brings about a new therapeutic option for acute promyelocytic leukemia.

Authors:  Ke Li; Feng Wang; Zhuo-Wei Hu
Journal:  Mol Cell Oncol       Date:  2017-06-16

9.  High throughput kinase inhibitor screens reveal TRB3 and MAPK-ERK/TGFβ pathways as fundamental Notch regulators in breast cancer.

Authors:  Julia Izrailit; Hal K Berman; Alessandro Datti; Jeffrey L Wrana; Michael Reedijk
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-14       Impact factor: 11.205

10.  TRIB3 confers radiotherapy resistance in esophageal squamous cell carcinoma by stabilizing TAZ.

Authors:  Sha Zhou; Shiliang Liu; Chuyong Lin; Yue Li; Liping Ye; Xianqiu Wu; Yunting Jian; Yuhu Dai; Ying Ouyang; Lei Zhao; Mengzhong Liu; Libing Song; Mian Xi
Journal:  Oncogene       Date:  2020-03-10       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.